Micro Emerging Active

RVMD stock initiated with buy rating on RAS(ON) platform potential

New narrative with limited coverage — still forming.

Score
0.5
Velocity
▲ 1.0
Articles
2
Sources
2

Top Movers

TickerSectorChange
RVMD
Healthcare+45.5%

Sentiment Timeline

Sector Performance

Stock Performance

Event Timeline

Apr 13, 2026
Revolution Medicines Stock Rises 39% Over Positive Topline Data From Daraxonrasib Study Bullish
Mar 30, 2026
Jefferies Highlights Revolution Medicines, Inc. (RVMD)’s RAS(ON) Platform in Coverage Initiation Neutral

Related Articles

Revolution Medicines Stock Rises 39% Over Positive Topline Data From Daraxonrasib Study

Nasdaq · Apr 13, 2026
Mixed

Timeline

First SeenMar 30, 2026
Last UpdatedMar 30, 2026